Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer

Published:2004-01 Issue:1 Volume:15 Page:95-99
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Alexopoulos A.,Tryfonopoulos D.,Karamouzis M.V.,Gerasimidis G.,Karydas I.,Kandilis K.,Stavrakakis J.,Stavrinides H.,Georganta C.,Ardavanis A.,Rigatos G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/1/95/333336/mdh028.pdf

Reference20 articles.

1. Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer;Valero;J Clin Oncol,1995

2. Advanced breast cancer: a phase II trial with gemcitabine;Carmichael;J Clin Oncol,1995

3. Advanced breast cancer: investigational role of gemcitabine;Carmichael;Eur J Cancer,1997

4. Single-agent gemcitabine is active in previously treated metastatic breast cancer;Spielmann;Oncology,2001

5. Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer;Zoli;Br J Cancer,1999

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapeutic Protocols for the Treatment of Breast Cancer;Chemotherapy Protocols and Infusion Sequence;2022

2. Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model;Cancer Genomics - Proteomics;2020

3. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy;Acta Biomaterialia;2017-10

4. Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2014-11-15

5. A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2012-02-17